Introduction: Who Should Undergo Diagnostics

When cervical cancer returns after treatment, it brings new challenges for both patients and doctors. Recurrent cervical cancer means that cancer cells have come back after a person has finished their initial treatment, whether that was surgery, radiation therapy, or chemotherapy. Knowing when to look for signs of recurrence is important because early detection can open doors to more treatment possibilities.^[1]

Most women who have been treated for cervical cancer should undergo regular follow-up diagnostics as part of their aftercare plan. Statistics show that approximately one-third of women with cervical cancer experience a recurrence during their follow-up period, and most of these relapses happen within the first two to three years after treatment.^[6] Studies have found that recurrence often occurs within approximately 20 months after the initial treatment ended.^[6]

Anyone who has completed treatment for cervical cancer should stay alert to their body’s signals. Some people with recurrent cervical cancer may not feel any symptoms at all in the early stages, which is why regular check-ups matter so much. However, others may develop warning signs that should prompt immediate medical attention. These symptoms include pelvic pain, lower back pain, chest pain, abnormal bleeding, vaginal discharge, or swelling in the legs and feet.^[6]

The likelihood of cancer returning depends on several factors. These include the initial cancer stage when it was first diagnosed, the type of treatment received, and the individual’s overall health status. For patients who had Federation of Gynecology and Obstetrics stage IB-IIA cancer, recurrence rates range from 11 to 22 percent. For those with more advanced stages IIB-IVA, the rates jump to 28 to 64 percent. In stage III to IVB cases, some studies report recurrence rates as high as 70 percent.^[6]

Certain risk factors make recurrence more likely. Research has identified that younger age, a lower number of births, a higher number of pregnancy losses, higher stage of cancer at initial diagnosis, and the presence of lymph node metastasis (cancer spread to lymph nodes) are all associated with increased risk of the cancer coming back.^[6]

Diagnostic Methods for Identifying Recurrence

When doctors suspect that cervical cancer has returned, they use a combination of different diagnostic tools to confirm the recurrence and understand where the cancer is located and how far it has spread. The choice of diagnostic method depends on what symptoms the patient is experiencing, where the cancer might have returned, and what treatment was given previously.^[5]

Physical Examination

The first step in detecting recurrent cervical cancer often begins with a thorough physical examination. During follow-up visits, doctors perform a pelvic examination to check for any unusual masses, lumps, or changes in the cervix, uterus, or surrounding pelvic organs. They may also conduct a digital rectal exam to feel for abnormalities near the rectum and lower pelvic area. While physical exams can provide important clues, they cannot detect all recurrences, especially those that are small or located in areas that are difficult to feel.^[3]

Imaging Studies

Imaging tests play a crucial role in detecting recurrent cervical cancer because they can reveal cancer that has come back in areas that cannot be felt during a physical exam. Different imaging methods show different parts of the body with varying levels of detail.

Magnetic Resonance Imaging (MRI) is particularly useful for detecting recurrent cervical cancer in the pelvis. This imaging technique uses magnets and radio waves to create detailed pictures of soft tissues. MRI can accurately define the size and extent of local recurrence in the cervix or nearby pelvic organs. It can also show whether the cancer has invaded adjacent organs such as the bladder, rectum, or vaginal walls. Because MRI provides such clear images of soft tissue structures, it is often the preferred method for evaluating local pelvic recurrence.^[5]

Computed Tomography (CT) scans use X-rays taken from different angles to create cross-sectional images of the body. CT scans are valuable for detecting cancer that has spread beyond the pelvis to distant sites such as the lungs, liver, or lymph nodes in the abdomen and chest. They can show enlarged lymph nodes or masses in organs far from where the cancer originally started.^[5]

Positron Emission Tomography (PET) scans, often combined with CT scans (PET/CT), can detect cancer throughout the entire body. During a PET scan, a small amount of radioactive sugar is injected into the bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as bright spots on the scan. PET/CT is especially helpful for finding cancer that has spread to distant sites, such as bones, distant lymph nodes, or organs far from the pelvis.^[5]

Ultrasound uses sound waves to create images of internal organs. A pelvic ultrasound or transvaginal ultrasound (where a probe is inserted into the vagina) can help visualize the uterus, cervix, and nearby structures. While ultrasound is less commonly used than MRI or CT for detecting recurrence, it can provide useful information in certain situations.^[3]

Laboratory Tests

Blood tests and other laboratory studies can provide additional information about whether cancer has returned. While no single blood test can definitively diagnose recurrent cervical cancer, certain tests can raise suspicion or provide supportive evidence.

Doctors may order blood tests to check for anemia (low red blood cell count), which can occur with abnormal vaginal bleeding. They may also test kidney and liver function to see if these organs are working properly, as cancer spread can sometimes affect their function. However, these tests are general indicators of health rather than specific markers of cancer recurrence.

Biopsy

A biopsy is the removal of a small piece of tissue for examination under a microscope. It is the only way to confirm with certainty that cancer has returned. If imaging tests or physical examination suggest recurrence, doctors will usually recommend a biopsy to confirm the diagnosis before starting treatment.^[3]

The type of biopsy performed depends on where the suspected cancer is located. If the recurrence appears to be in the cervix or vagina, the doctor may perform a simple biopsy during a pelvic exam. If the cancer appears to be in a lymph node, the doctor may use a needle to remove cells from the node for testing. For suspected recurrence in other organs, more specialized biopsy techniques may be needed.

Examination Under Anesthesia

In some cases, doctors may perform an examination while the patient is under anesthesia. This allows for a more thorough pelvic examination without causing discomfort. During this procedure, the doctor can carefully feel for masses or abnormalities and may take biopsies if needed. This is sometimes done when a thorough examination is difficult while the patient is awake.

Diagnostics for Clinical Trial Qualification

Clinical trials test new treatments or combinations of treatments to find better ways to manage recurrent cervical cancer. To participate in a clinical trial, patients must meet specific criteria, and diagnostic tests play an important role in determining eligibility.

Performance Status Assessment

Before enrolling in a clinical trial, doctors assess a patient’s overall health and ability to perform daily activities. This is called performance status. Doctors use standardized scales to rate how well a person can function. A good performance status generally means the person can care for themselves and carry out normal activities with minimal assistance. Most clinical trials require participants to have a certain level of performance status to ensure they can tolerate the experimental treatment.

Imaging Documentation

Clinical trials require precise documentation of where the cancer is located and how much disease is present. Patients typically need recent imaging studies, such as CT scans, MRI, or PET scans, to show the extent of their cancer. These images must be taken within a specific timeframe before enrolling in the trial, usually within a few weeks. The imaging results help researchers measure whether the experimental treatment is working by comparing images taken before and after treatment.^[5]

Tissue Testing

Many modern clinical trials require specific tests on the cancer tissue itself. For example, some trials test whether the cancer has certain proteins or genetic markers. One such marker is PD-L1, a checkpoint protein that some cancer cells have on their surface. Certain immunotherapy drugs work only in cancers that have PD-L1, so trials testing these drugs require proof that the cancer has this protein before a patient can participate.^[3]

To perform these tests, doctors need a tissue sample from the recurrent cancer. This might come from a recent biopsy or, in some cases, from tissue saved from previous surgeries. The tissue is tested in a specialized laboratory that looks for specific markers or genetic changes. These results help match patients to clinical trials that are most likely to benefit them.

Blood Tests and Organ Function

Clinical trials also require extensive blood testing to ensure that patients are healthy enough to receive experimental treatments. These tests typically include a complete blood count to check red blood cells, white blood cells, and platelets. Low counts might make a patient ineligible if the treatment could further lower these numbers.

Tests of kidney and liver function are also standard requirements. The kidneys and liver are responsible for processing and eliminating many medications from the body. If these organs are not working well, the treatment could build up to dangerous levels or cause serious side effects. Most trials have specific cutoff values for kidney and liver function tests, and patients whose results fall outside these ranges may not qualify.

Baseline Measurements

Before starting a clinical trial, researchers establish baseline measurements of the cancer and the patient’s health. This includes measuring the size of any tumors using imaging studies, recording symptoms, and assessing quality of life through questionnaires. These baseline measurements serve as a comparison point to determine whether the experimental treatment is helping.

Confirmation of Recurrence

All clinical trials for recurrent cervical cancer require confirmed evidence that the cancer has indeed returned. This usually means having both imaging evidence and biopsy confirmation. Some trials may accept imaging evidence alone in situations where a biopsy would be too risky or difficult to obtain, but most require tissue proof. This strict requirement ensures that the trial is studying the right group of patients and that the results will be meaningful.